UCB Ups Funding For M&A, Debt Repayment By Selling Kremers Urban
This article was originally published in The Pink Sheet Daily
Executive Summary
Belgium’s mid-sized pharma sells its U.S. generics business to two private equity companies, improving its flexibility to acquire new assets and businesses, and allowing it to pay down debt.